Sigmon A - Search Results

1

The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.

Karuppagounder SS, Wang H, Kelly T, Rush R, Nguyen R, Bisen S, Yamashita Y, Sloan N, Dang B, Sigmon A, Lee HW, Marino Lee S, Watkins L, Kim E, Brahmachari S, Kumar M, Werner MH, Dawson TM, Dawson VL. Karuppagounder SS, et al. Among authors: sigmon a. Sci Transl Med. 2023 Jan 18;15(679):eabp9352. doi: 10.1126/scitranslmed.abp9352. Epub 2023 Jan 18. Sci Transl Med. 2023. PMID: 36652533

2

Prognostic Value of a Structural Brain MRI Score in the Acute Phase of Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.

Nelson SE, Piran P, Hua J, Sigmon A, Weiner C, Sair HI, Suarez JI, Stevens RD. Nelson SE, et al. Among authors: sigmon a. Neurocrit Care. 2021 Oct;35(2):501-505. doi: 10.1007/s12028-021-01209-0. Epub 2021 Mar 9. Neurocrit Care. 2021. PMID: 33751446

3

External ventricular drain use is associated with functional outcome in aneurysmal subarachnoid hemorrhage.

Nelson SE, Suarez JI, Sigmon A, Hua J, Weiner C, Sair HI, Stevens RD. Nelson SE, et al. Among authors: sigmon a. Neurol Res Pract. 2022 Jun 27;4(1):25. doi: 10.1186/s42466-022-00189-6. Neurol Res Pract. 2022. PMID: 35754049 Free PMC article.

4

Crystal structures of three newly synthesized flavanone hydrazones.

Yennawar HP, Sigmon A, Margulis E. Yennawar HP, et al. Among authors: sigmon a. Acta Crystallogr E Crystallogr Commun. 2023 Feb 28;79(Pt 3):236-240. doi: 10.1107/S2056989023001184. eCollection 2023 Feb 1. Acta Crystallogr E Crystallogr Commun. 2023. PMID: 36909992 Free PMC article.

5

Crystal structure of racemic (R/S,E)-2-(4-hy-droxy-phen-yl)-4-(2-phenyl-hydrazin-1-yl-idene)chromane-5,7-diol ethanol monosolvate.

Yennawar HP, Sigmon A. Yennawar HP, et al. Among authors: sigmon a. Acta Crystallogr E Crystallogr Commun. 2022 Mar 1;78(Pt 4):346-348. doi: 10.1107/S2056989022002079. eCollection 2022 Apr 1. Acta Crystallogr E Crystallogr Commun. 2022. PMID: 35492281 Free PMC article.

6

Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes.

Wagner HR, Burns BJ, Broadhead WE, Yarnall KS, Sigmon A, Gaynes BN. Wagner HR, et al. Among authors: sigmon a. Psychol Med. 2000 Nov;30(6):1377-90. doi: 10.1017/s0033291799002998. Psychol Med. 2000. PMID: 11097078

7

Caregivers and elderly relatives. The prevalence of caregiving in a family practice.

Andolsek KM, Clapp-Channing NE, Gehlbach SH, Moore I, Proffitt VS, Sigmon A, Warshaw GA. Andolsek KM, et al. Among authors: sigmon a. Arch Intern Med. 1988 Oct;148(10):2177-80. doi: 10.1001/archinte.148.10.2177. Arch Intern Med. 1988. PMID: 3178375

8

Alzheimer's disease: a study of epidemiological aspects.

Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T. Heyman A, et al. Among authors: sigmon ah. Ann Neurol. 1984 Apr;15(4):335-41. doi: 10.1002/ana.410150406. Ann Neurol. 1984. PMID: 6742780

9

Alzheimer's disease: genetic aspects and associated clinical disorders.

Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T, Helms MJ, Swift M. Heyman A, et al. Among authors: sigmon ah. Ann Neurol. 1983 Nov;14(5):507-15. doi: 10.1002/ana.410140503. Ann Neurol. 1983. PMID: 6228188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters